Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs2292096
rs2292096
CAMSAP2
0.810 GeneticVariation GWASDB Two-stage genome-wide association study identifies variants in CAMSAP1L1 as susceptibility loci for epilepsy in Chinese. 22116939

2012
dbSNP: rs2292096
rs2292096
CAMSAP2
0.810 GeneticVariation BEFREE Here, we report that rs2292096 genotypes tended to associate with expression of CAMSAP1L1 RNA in the temporal lobe (p=0.054) and hippocampus (p=0.20) of epilepsy surgery patients, with expression tending to increase with the G allele. 24148305

2013
dbSNP: rs2292096
rs2292096
CAMSAP2
0.810 GeneticVariation GWASCAT Two-stage genome-wide association study identifies variants in CAMSAP1L1 as susceptibility loci for epilepsy in Chinese. 22116939

2012
dbSNP: rs111908689
rs111908689 		0.700 GeneticVariation GWASCAT A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine. 30868120

2019
dbSNP: rs11214136
rs11214136
BCO2
0.700 GeneticVariation GWASCAT A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine. 30868120

2019
dbSNP: rs11663316
rs11663316 		0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs118166657
rs118166657 		0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs13287547
rs13287547
C9orf92
0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs1394074
rs1394074
OLFML3
0.700 GeneticVariation GWASCAT A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine. 30868120

2019
dbSNP: rs139427007
rs139427007
LOC105369927 ; LOC105369928
0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs1429264
rs1429264
COTL1
0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs143543475
rs143543475 		0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs146173241
rs146173241 		0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs148173957
rs148173957
LOC105378976
0.700 GeneticVariation GWASCAT A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine. 30868120

2019
dbSNP: rs150435906
rs150435906
LOC107986950
0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs2930491
rs2930491 		0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs4895178
rs4895178 		0.700 GeneticVariation GWASCAT A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine. 30868120

2019
dbSNP: rs55949311
rs55949311
LOC105370210
0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs62270313
rs62270313
EPHB1
0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs71547482
rs71547482 		0.700 GeneticVariation GWASCAT A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine. 30868120

2019
dbSNP: rs7328626
rs7328626 		0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs7461897
rs7461897 		0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs75078187
rs75078187
LOC100506422
0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs9596837
rs9596837 		0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs970510
rs970510
LOC102725148
0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015